Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America

Diabetes Research and Clinical Practice

Volumn 88, Issue 1, 2010, Pages 7-13

  Gagliardino, Juan J ^a   Kleinebreil, Line ^b   Colagiuri, Stephen ^c   Flack, Jeff ^c   Caporale, Joaquín E ^a   Siri, Fernando ^a   Clark Jr , Charles ^d  

^a University of La Plata CONICET   (Argentina)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Access and evaluation; Diabetes mellitus; Health care quality; Monitoring; Risk assessment; Risk factors

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BODY MASS; BUDGET; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE DURATION; FEMALE; FRANCE; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH AND CENTRAL AMERICA; SYSTOLIC BLOOD PRESSURE;

AGED; ANALYSIS OF VARIANCE; AUSTRALIA; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; HEALTH BEHAVIOR; HEALTH SERVICES; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PROGRAM EVALUATION; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; SELF CARE; TREATMENT OUTCOME;

EID: 77649239165     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.12.024     Document Type: Article

References (29)

1. Mc Carty D., and Zimmet P. Diabetes 1994 to 2010. Global Estimates and Projections (1994), International Diabetes Institute, Melbourne, Australia
2. J. Gagliardino, E. Olivera. The regions and their health care systems: Latin American, in: W. Gruber, T. Lander, B. Leese, T. Songer, H. Williams (Eds.), Economics of Diabetes and Diabetes Care. A Report of the Diabetes Health Economics Study Group, 1997, pp. 51-59.
3. Gagliardino J.J., De La Hera M., and Siri F. Evaluación preliminar de la calidad de atención de personas con diabetes en Argentina. Rev. Soc. Arg. Diabetes 35 (2001) 121-133
4. Grant R.W., Buse J.B., Meigs J.B., and University HealthSystem Consortium Diabetes Benchmarking Project Team. Quality of diabetes care in US academic medical centers: low rates of medical regimen change. Diabetes Care 28 (2005) 337-342
5. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329 (1993) 977-986
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
7. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 238 (2003) 383-393
8. Gaede P., Lund-Andersen H., Parving H.H., and Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 358 (2008) 580-591
9. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J., Neal B., Billot L., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358 (2008) 2560-2572
10. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358 (2008) 2545-2559
11. Skyler J.S., Bergenstal R., Bonow R.O., Buse J., Deedwania P., Gale E.A., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 119 (2009) 351-357
12. Ray K.K., Seshasai S.R.K., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
13. Herman W.H., and Eastman R.C. The effects of treatment on the direct costs of diabetes. Diabetes Care 21 Suppl.3 (1998) C19-C24
14. Piwernetz K., Home P.D., Staehr Johansen K., Kleinebreil L., Vermeij D., and Storms G.E.M.G. DIABCARE Quality Network in Europe. TELEMATICS Project within the St. Vincent Declaration. Consensus Meeting. Diab. Nutr. Metab. 8 (1995) 243-249
15. Gagliardino J.J. Una iniciativa de la DOTA para implementar el control de calidad de atención (QUALIDIAB) en América Latina y el Caribe. Revista de la ALAD 8 (2000) 26-35
16. J.R. Flack, S. Colagiuri, on behalf of the National Association of Diabetes Centres, Australian National Diabetes Information Audit & Benchmarking [ANDIAB] 2000. Final Report, September 2000.
17. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes (2005), International Diabetes Federation, Brusells
18. Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29 (2006) 1963-1972
19. Lebovitz H.E., Austin M.M., Blonde L., Davidson J.A., Del Prato S., Gavin III J.R., et al. ACE/AACE Diabetes Recommendations Implementation Writing Committee, ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. Endocr. Pract. 12 Suppl. 1 (2006) 6-12
20. Cull C.A., Manley S.E., Stratton I.M., Neil H.A., Ross I.S., Holman R.R., et al. Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin. Chem. 43 (1997) 1913-1918
21. Wood D., De Baker G., Faegerman O., Grahan I., Mancia G., and Pyorala K. Together with Members of the Task Force, Prevention of coronary disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur. Heart J. 19 (1998) 1434-1503
22. Gudbjornsdottir S., Cederholm J., Nilson P.M., and Eliasson B. Steering Committee of the Swedish National Diabetes Register. The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26 (2003) 1270-1276
23. World Health Organization, WHO, Obesity. Preventing and Managing the Global Epidemic. Report of the WHO Consultation of Obesity, World Health Organisation. Geneva, WHO, 1998.
24. Grundy S., Cleeman J., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239
25. Mazze R., Deeb L., and Palumbo P.J. Altering physicians' practice patterns-a nationwide educational experiment: evaluation of the Clinical Education Program of the American Diabetes Association. Diabetes Care 9 (1986) 420-425
26. Gagliardino J., Etchegoyen G., and PEDNID-LA Research Group. A model education program for people with type 2 diabetes: a cooperative Latin-American implementation study. Diabetes Care 24 (2001) 1001-1007
27. Norris S., Lau J., Smith S., Schmid C., and Engelgau M. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25 (2002) 1159-1171
28. Gagliardino J.J., Olivera E., Etchegoyen G.S., Guidi M.L., Caporale J.E., Martella A., et al. PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res. Clin. Pract. 72 (2006) 284-291
29. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287 (2002) 2542-2551